rdf:type |
|
lifeskim:mentions |
umls-concept:C0021641,
umls-concept:C0030705,
umls-concept:C0123677,
umls-concept:C0199782,
umls-concept:C0332173,
umls-concept:C0332293,
umls-concept:C0332307,
umls-concept:C0439064,
umls-concept:C0443315,
umls-concept:C0549178,
umls-concept:C0574032,
umls-concept:C0907402
|
pubmed:issue |
3
|
pubmed:dateCreated |
2005-2-28
|
pubmed:abstractText |
Multiple daily injection (MDI) therapy of bolus insulin aspart and basal insulin glargine was compared with continuous subcutaneous insulin infusion (CSII) with aspart in type 1 diabetic patients previously treated with CSII.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0149-5992
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
533-8
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:15735183-Adult,
pubmed-meshheading:15735183-Biological Markers,
pubmed-meshheading:15735183-Blood Glucose,
pubmed-meshheading:15735183-Body Mass Index,
pubmed-meshheading:15735183-Diabetes Mellitus, Type 1,
pubmed-meshheading:15735183-Drug Administration Schedule,
pubmed-meshheading:15735183-Female,
pubmed-meshheading:15735183-Fructosamine,
pubmed-meshheading:15735183-Hemoglobin A, Glycosylated,
pubmed-meshheading:15735183-Humans,
pubmed-meshheading:15735183-Insulin,
pubmed-meshheading:15735183-Insulin, Long-Acting,
pubmed-meshheading:15735183-Insulin Aspart,
pubmed-meshheading:15735183-Insulin Infusion Systems,
pubmed-meshheading:15735183-Male
|
pubmed:year |
2005
|
pubmed:articleTitle |
Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.
|
pubmed:affiliation |
University of Washington, Seattle, WA, USA. ihirsch@u.washington.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|